iAnthus Capital Holdings (FRA:2IA) Accumulated Depreciation: €0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is iAnthus Capital Holdings Accumulated Depreciation?

iAnthus Capital Holdings FRA:2IA Accumulated Depreciation is €0.0 Mil as of Jun. 2026. The stock has 4 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

iAnthus Capital Holdings's quarterly accumulated depreciation declined from Dec. 2025 (€-46.1 Mil) to Mar. 2026 (€0.0 Mil) but then stayed the same from Mar. 2026 (€0.0 Mil) to Jun. 2026 (€0.0 Mil).

iAnthus Capital Holdings's annual accumulated depreciation declined from Dec. 2023 (€-47.3 Mil) to Dec. 2024 (€-44.9 Mil) but then increased from Dec. 2024 (€-44.9 Mil) to Dec. 2025 (€-46.1 Mil).


iAnthus Capital Holdings Accumulated Depreciation Related Terms


iAnthus Capital Holdings Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for iAnthus Capital Holdings's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iAnthus Capital Holdings Accumulated Depreciation Chart

iAnthus Capital Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -30.99 -38.73 -47.28 -44.93 -46.13

iAnthus Capital Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -46.13 0.00 0.00

iAnthus Capital Holdings Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of €0.0 Mil mean?
iAnthus Capital Holdings (FRA:2IA) has a Accumulated Depreciation of €0.0 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on iAnthus Capital Holdings and its competitors.
Is iAnthus Capital Holdings' Accumulated Depreciation too high?
iAnthus Capital Holdings' current Accumulated Depreciation is €0.0 Mil.
How does iAnthus Capital Holdings' Accumulated Depreciation compare to ZTS?
iAnthus Capital Holdings' Accumulated Depreciation of €0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on iAnthus Capital Holdings and its competitors. iAnthus Capital Holdings's current Accumulated Depreciation is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iAnthus Capital Holdings stock overvalued right now?
iAnthus Capital Holdings (FRA:2IA) has a current Accumulated Depreciation of €0.0 Mil. The current Accumulated Depreciation is €0.0 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For iAnthus Capital Holdings (FRA:2IA), the current Accumulated Depreciation is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iAnthus Capital Holdings Business Description

Other Exchanges ITHUF:USAIAN:Canada
Address 214 King Street West, Suite 314, Toronto, ON, CAN, M5H 3S6
iAnthus Capital Holdings Inc is a vertically-integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities and a developer, producer, and distributor of branded cannabis products in the United States. Its Cannabis product offerings include flower and trim, products containing cannabis flower and trim (such as packaged flower and pre-rolls), cannabis infused products (such as topical creams and edibles), and products containing cannabis extracts (such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures). The company's reportable operating segments are the Eastern Region, which generates the maximum revenue, and the Western Region.